Hi All, I’m not sure how old this is but what got me was the...

Hi All,
I’m not sure how old this is but what got me was the statement “Apricitabine received fast-track approval status from the FDA”

It’s a good read anyway

Apricitabine, previously known as AVX754 and SPD754, is a nucleoside reverse transcriptase inhibitor (NRTI). Apricitabine is the negative enantiomer of a member of the 4-thio heterosubstituted nucleoside analogue class. It is a novel cytidine analogue with activity against HIV strains that are resistant to other NRTIs.
Apricitabine is a deoxycytidine analogue entering Phase IIb studies for the treatment of HIV infection. It is being studied as a first choice, second regimen drug for the treatment of HIV infection in people who have failed treatment with lamivudine. Apricitabine received fast-track approval status from the FDA.

This is the link to the whole story!
http://aidsinfo.nih.gov/DrugsNew/DrugDetailT.aspx?int_id=415

A